The Brucella abortus S19 ΔvjbR Live Vaccine Candidate Is Safer than S19 and Confers Protection against Wild-Type Challenge in BALB/c Mice When Delivered in a Sustained-Release Vehicle
dc.creator | A. M. Arenas-Gamboa | |
dc.creator | T. A. Ficht | |
dc.creator | M. M. Kahl-McDonagh | |
dc.creator | G. Gomez | |
dc.creator | A. C. Rice-Ficht | |
dc.date.accessioned | 2019-10-10T16:50:26Z | |
dc.date.available | 2019-10-10T16:50:26Z | |
dc.date.issued | 2009 | |
dc.identifier.issn | 0019-9567 | |
dc.identifier.issn | 1070-6313 | |
dc.identifier.issn | 1098-5522 | |
dc.identifier.uri | https://hdl.handle.net/1969.1/182819 | |
dc.format.extent | 1 | en |
dc.publisher | Infection and Immunity | |
dc.relation.ispartof | 1foldr Import 2019-10-08 Batch 9 | en |
dc.relation.uri | 10.1128/IAI.01017-08 | en |
dc.title | The Brucella abortus S19 ΔvjbR Live Vaccine Candidate Is Safer than S19 and Confers Protection against Wild-Type Challenge in BALB/c Mice When Delivered in a Sustained-Release Vehicle | en |